Aadi Bioscience, INC Form 4 insider transactions

Loretta M. Itri, Chief Medical Officer of Aadi Bioscience, Inc., reports the acquisition of stock options and restricted stock units as part of her compensation.

A Form 4 filing reveals that Aadi Bioscience CEO David James Lennon acquired stock options and restricted stock units (RSUs) on March 1, 2024, related to his compensation and continued service with the company.

A Form 4 filing reveals that Aadi Bioscience's CFO, Scott M. Giacobello, was granted stock options and restricted stock units on March 1, 2024.